{"id":"https://openalex.org/W1965168280","doi":"https://doi.org/10.2169/internalmedicine.51.8314","title":"Rapid Amelioration of Hyperglycemia Facilitated by Dasatinib in a Chronic Myeloid Leukemia Patient with type 2 Diabetes Mellitus","display_name":"Rapid Amelioration of Hyperglycemia Facilitated by Dasatinib in a Chronic Myeloid Leukemia Patient with type 2 Diabetes Mellitus","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W1965168280","doi":"https://doi.org/10.2169/internalmedicine.51.8314","mag":"1965168280","pmid":"https://pubmed.ncbi.nlm.nih.gov/23037470"},"language":"en","primary_location":{"id":"doi:10.2169/internalmedicine.51.8314","doi":"https://doi.org/10.2169/internalmedicine.51.8314","is_oa":true,"landing_page_url":"https://doi.org/10.2169/internalmedicine.51.8314","pdf_url":"https://www.jstage.jst.go.jp/article/internalmedicine/51/19/51_51.8314/_pdf","source":{"id":"https://openalex.org/S154471048","display_name":"Internal Medicine","issn_l":"0918-2918","issn":["0918-2918","1349-7235"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313351","host_organization_name":"The Japanese Society of Internal Medicine","host_organization_lineage":["https://openalex.org/P4310313351"],"host_organization_lineage_names":["The Japanese Society of Internal Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Internal Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/internalmedicine/51/19/51_51.8314/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112355132","display_name":"Keiko Ono","orcid":"https://orcid.org/0009-0002-3441-4191","observed_orcids":["https://orcid.org/0009-0002-3441-4191"]},"institutions":[{"id":"https://openalex.org/I4405253467","display_name":"Kumamoto Shinto General Hospital","ror":"https://ror.org/00pm9ra94","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405253467"]},{"id":"https://openalex.org/I96036126","display_name":"Kumamoto University","ror":"https://ror.org/02cgss904","country_code":"JP","type":"education","lineage":["https://openalex.org/I96036126"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Keiko Ono","raw_affiliation_strings":["Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan","Department of Metabolism and Endocrinology, Kumamoto Shinto General Hospital (formerly NTT West Kyushu Hospital), Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan","institution_ids":["https://openalex.org/I96036126"]},{"raw_affiliation_string":"Department of Metabolism and Endocrinology, Kumamoto Shinto General Hospital (formerly NTT West Kyushu Hospital), Japan","institution_ids":["https://openalex.org/I4405253467"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003088921","display_name":"Hitoshi Suzushima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405253467","display_name":"Kumamoto Shinto General Hospital","ror":"https://ror.org/00pm9ra94","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405253467"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hitoshi Suzushima","raw_affiliation_strings":["Department of Hematology, Kumamoto Shinto General Hospital (formerly NTT West Kyushu Hospital), Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Kumamoto Shinto General Hospital (formerly NTT West Kyushu Hospital), Japan","institution_ids":["https://openalex.org/I4405253467"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040430317","display_name":"Yuko Watanabe","orcid":"https://orcid.org/0000-0002-0598-856X","observed_orcids":["https://orcid.org/0000-0002-0598-856X"]},"institutions":[{"id":"https://openalex.org/I4405253467","display_name":"Kumamoto Shinto General Hospital","ror":"https://ror.org/00pm9ra94","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405253467"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuko Watanabe","raw_affiliation_strings":["Department of Hematology, Kumamoto Shinto General Hospital (formerly NTT West Kyushu Hospital), Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Kumamoto Shinto General Hospital (formerly NTT West Kyushu Hospital), Japan","institution_ids":["https://openalex.org/I4405253467"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019857338","display_name":"Yoshitaka Kikukawa","orcid":"https://orcid.org/0000-0002-1111-4666","observed_orcids":["https://orcid.org/0000-0002-1111-4666"]},"institutions":[{"id":"https://openalex.org/I4405253467","display_name":"Kumamoto Shinto General Hospital","ror":"https://ror.org/00pm9ra94","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405253467"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshitaka Kikukawa","raw_affiliation_strings":["Department of Hematology, Kumamoto Shinto General Hospital (formerly NTT West Kyushu Hospital), Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Kumamoto Shinto General Hospital (formerly NTT West Kyushu Hospital), Japan","institution_ids":["https://openalex.org/I4405253467"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111696256","display_name":"Taizou Shimomura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405253467","display_name":"Kumamoto Shinto General Hospital","ror":"https://ror.org/00pm9ra94","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405253467"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Taizou Shimomura","raw_affiliation_strings":["Department of Hematology, Kumamoto Shinto General Hospital (formerly NTT West Kyushu Hospital), Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Kumamoto Shinto General Hospital (formerly NTT West Kyushu Hospital), Japan","institution_ids":["https://openalex.org/I4405253467"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004326764","display_name":"Noboru Furukawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I96036126","display_name":"Kumamoto University","ror":"https://ror.org/02cgss904","country_code":"JP","type":"education","lineage":["https://openalex.org/I96036126"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Noboru Furukawa","raw_affiliation_strings":["Center for Medical Education and Research, Faculty of Life Sciences, Kumamoto University, Japan","Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Medical Education and Research, Faculty of Life Sciences, Kumamoto University, Japan","institution_ids":["https://openalex.org/I96036126"]},{"raw_affiliation_string":"Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan","institution_ids":["https://openalex.org/I96036126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048119729","display_name":"Tatsuya Kawaguchi","orcid":"https://orcid.org/0009-0001-8079-1759","observed_orcids":["https://orcid.org/0009-0001-8079-1759"]},"institutions":[{"id":"https://openalex.org/I4210122547","display_name":"Kumamoto University Hospital","ror":"https://ror.org/02vgs9327","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210122547"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tatsuya Kawaguchi","raw_affiliation_strings":["Department of Hematology and Infectious Diseases, Kumamoto University Hospital, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Infectious Diseases, Kumamoto University Hospital, Japan","institution_ids":["https://openalex.org/I4210122547"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067248419","display_name":"Eiichi Araki","orcid":"https://orcid.org/0000-0002-4064-7525","observed_orcids":["https://orcid.org/0000-0002-4064-7525"]},"institutions":[{"id":"https://openalex.org/I96036126","display_name":"Kumamoto University","ror":"https://ror.org/02cgss904","country_code":"JP","type":"education","lineage":["https://openalex.org/I96036126"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Eiichi Araki","raw_affiliation_strings":["Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan","institution_ids":["https://openalex.org/I96036126"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.0444,"has_fulltext":true,"cited_by_count":50,"citation_normalized_percentile":{"value":0.87034422,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"51","issue":"19","first_page":"2763","last_page":"2766"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9291999936103821,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9291999936103821,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.01769999973475933,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.005499999970197678,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.996999979019165},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9879999756813049},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.9610000252723694},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9110000133514404},{"id":"https://openalex.org/keywords/insulin-requirement","display_name":"insulin requirement","score":0.5460000038146973},{"id":"https://openalex.org/keywords/c-peptide","display_name":"C-peptide","score":0.8600000143051147},{"id":"https://openalex.org/keywords/beta-cell-function","display_name":"beta-cell function","score":0.7080000042915344},{"id":"https://openalex.org/keywords/imatinib-resistance","display_name":"imatinib resistance","score":0.878000020980835},{"id":"https://openalex.org/keywords/glucose-metabolism","display_name":"glucose metabolism","score":0.9430000185966492}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9460409879684448},{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.9260556101799011},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.7473984956741333},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6963886022567749},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5803524851799011},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5789685249328613},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.5523260831832886},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.5247602462768555},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.4781799614429474},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.46247875690460205},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4437781572341919},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.08006206154823303},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.05986374616622925}],"mesh":[{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069439","descriptor_name":"Dasatinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006943","descriptor_name":"Hyperglycemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006943","descriptor_name":"Hyperglycemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006943","descriptor_name":"Hyperglycemia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015465","descriptor_name":"Leukemia, Myeloid, Accelerated Phase","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D015465","descriptor_name":"Leukemia, Myeloid, Accelerated Phase","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2169/internalmedicine.51.8314","doi":"https://doi.org/10.2169/internalmedicine.51.8314","is_oa":true,"landing_page_url":"https://doi.org/10.2169/internalmedicine.51.8314","pdf_url":"https://www.jstage.jst.go.jp/article/internalmedicine/51/19/51_51.8314/_pdf","source":{"id":"https://openalex.org/S154471048","display_name":"Internal Medicine","issn_l":"0918-2918","issn":["0918-2918","1349-7235"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313351","host_organization_name":"The Japanese Society of Internal Medicine","host_organization_lineage":["https://openalex.org/P4310313351"],"host_organization_lineage_names":["The Japanese Society of Internal Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Internal Medicine","raw_type":"journal-article"},{"id":"pmid:23037470","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23037470","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Internal medicine (Tokyo, Japan)","raw_type":"Case Reports"}],"best_oa_location":{"id":"doi:10.2169/internalmedicine.51.8314","doi":"https://doi.org/10.2169/internalmedicine.51.8314","is_oa":true,"landing_page_url":"https://doi.org/10.2169/internalmedicine.51.8314","pdf_url":"https://www.jstage.jst.go.jp/article/internalmedicine/51/19/51_51.8314/_pdf","source":{"id":"https://openalex.org/S154471048","display_name":"Internal Medicine","issn_l":"0918-2918","issn":["0918-2918","1349-7235"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313351","host_organization_name":"The Japanese Society of Internal Medicine","host_organization_lineage":["https://openalex.org/P4310313351"],"host_organization_lineage_names":["The Japanese Society of Internal Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Internal Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1965168280.pdf","grobid_xml":"https://content.openalex.org/works/W1965168280.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W1987411639","https://openalex.org/W1997764773","https://openalex.org/W1997842448","https://openalex.org/W2035454060","https://openalex.org/W2039771828","https://openalex.org/W2053411009","https://openalex.org/W2056823373","https://openalex.org/W2094888641","https://openalex.org/W2130845505","https://openalex.org/W2143076346","https://openalex.org/W2143873708","https://openalex.org/W2150568560","https://openalex.org/W2172242821"],"related_works":["https://openalex.org/W4318831624","https://openalex.org/W2039771828","https://openalex.org/W2890015868","https://openalex.org/W3213960823","https://openalex.org/W2254132687","https://openalex.org/W2130845505","https://openalex.org/W3018029206","https://openalex.org/W2899447497","https://openalex.org/W2761298643","https://openalex.org/W4310127429"],"abstract_inverted_index":{"Tyrosine":[0],"kinase":[1],"inhibitors":[2],"(TKIs)":[3],"have":[4],"been":[5],"shown":[6],"to":[7,40,50],"affect":[8],"glucose":[9,54],"metabolism":[10],"in":[11],"patients":[12],"with":[13],"chronic":[14],"myeloid":[15],"leukemia":[16],"(CML);":[17],"however,":[18],"their":[19],"precise":[20],"mechanism":[21],"of":[22,31,47,59,88],"action":[23],"remains":[24],"unknown.":[25],"We":[26],"herein":[27],"report":[28],"the":[29,57,61,76,86],"case":[30],"a":[32],"57-year-old":[33],"diabetic":[34,97],"CML":[35,98],"patient":[36],"who":[37,102],"was":[38,70],"resistant":[39],"imatinib":[41],"and":[42,67],"initially":[43],"required":[44],"20":[45],"units":[46],"insulin":[48,63,68,89,104],"daily":[49],"control":[51],"his":[52],"blood":[53],"levels.":[55],"After":[56],"initiation":[58],"dasatinib,":[60],"patient's":[62],"requirements":[64],"declined":[65],"rapidly":[66],"treatment":[69],"discontinued":[71],"within":[72],"two":[73],"weeks.":[74],"Meanwhile,":[75],"fasting":[77],"C-peptide":[78],"immunoreactivity":[79],"increased":[80],"two-fold,":[81],"suggesting":[82],"that":[83],"dasatinib":[84],"facilitated":[85],"recovery":[87],"production.":[90],"Dasatinib":[91],"may":[92],"therefore":[93],"be":[94],"beneficial":[95],"for":[96],"patients,":[99],"especially":[100],"those":[101],"require":[103],"treatment.":[105]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}